Intrarenal serotonin, dopamine, and phosphate handling in remnant kidneys

Abstract

Background. Serotonin (5-HT) and dopamine (DA) are intrarenal autocrine/paracrine substances that regulate phosphate reabsorption. The present studies explored intrarenal serotonin and DA metabolism and the implications for phosphate homeostasis in rats with remnant kidneys, a model for renal failure. Methods. The intrarenal productions of serotonin and DA were determined from measurements of renal interstitial fluid (microdialysate) and urine in rats with remnant or intact kidneys. In clearance studies, the effects of infusion of methiothepin, a serotonin receptor antagonist, or gludopa, a renal selective DA precursor, on phosphate and sodium excretion were determined in rats with a remnant or intact kidneys. Results. Renal interstitial serotonin (5-HT, 3.4 ± 0.9 pg/min) was fourfold higher than DA (0.6 ± 0.1 pg/min) in remnant kidneys. Conversely, urinary excretion of serotonin was fourfold less than DA in rats with a remnant kidney (5-HT 0.4 ± 0.02 vs. DA 1.5 ± 0.1 ng/min). Infusion of methiothepin or gludopa significantly increased the fractional excretion of phosphate (FEPi) in rats with a remnant kidney from 54 ± 3 to 67 ± 7% (P < 0.05) and from 36 ± 10% to 51 ± 13% (P < 0.05), respectively. Conclusion. We conclude that serotonin preferentially accumulates in the renal interstitium, whereas DA exits primarily via the tubular lumen. Phosphate excretion is increased by both the acute infusion of the serotonin receptor antagonist and the infusion of gludopa, suggesting that both serotonin and DA modulate phosphate excretion in rats with remnant kidneys.